On October 6, 2025, INVO Fertility, Inc. reported that an institutional investor exercised their right to acquire 200 shares of Series C-2 Convertible Preferred Stock for a total of $200,000, adjusting the conversion price to $0.6643 per share.
AI Assistant
INVO FERTILITY INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.